CXCR4 and breast carcinoma: There are several CXCR4 inhibitors under clinical trials for the treatment of multiple myeloma, small cell lung cancer, and leukemia (Cooper et al., 2017; Salgia et al., 2017; Ghobrial et al., 2019), although none has been reported for breast cancer.